BRAINSTORM CELL THERAPEUTICS INC. Foreign Pre-Tax Income
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Foreign Pre-Tax Income of -$5.24 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign · last filed 2026-03-31
- BRAINSTORM CELL THERAPEUTICS INC. income (loss) from continuing operations before income taxes, foreign for fiscal 2025 was -$5.24M.
- BRAINSTORM CELL THERAPEUTICS INC. income (loss) from continuing operations before income taxes, foreign for fiscal 2024 was -$5.48M.
- BRAINSTORM CELL THERAPEUTICS INC. income (loss) from continuing operations before income taxes, foreign for fiscal 2023 was -$8.36M.
- BRAINSTORM CELL THERAPEUTICS INC. income (loss) from continuing operations before income taxes, foreign for fiscal 2022 was -$14.29M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Foreign 12 month |
|---|---|
| 2025-12-31 | -$5.24M 10-K · filed 2026-03-31 |
| 2024-12-31 | -$5.48M 10-K · filed 2026-03-31 |
| 2023-12-31 | -$8.36M 10-K · filed 2025-03-31 |
| 2022-12-31 | -$14.29M 10-K · filed 2024-04-01 |
| 2021-12-31 | -$16.10M 10-K · filed 2023-03-30 |
| 2020-12-31 | -$23.23M 10-K · filed 2022-03-28 |
| 2019-12-31 | -$18.88M 10-K · filed 2021-02-04 |
| 2018-12-31 | -$10.33M 10-K · filed 2020-02-18 |
| 2017-12-31 | -$2.42M 10-K · filed 2019-04-01 |
| 2016-12-31 | -$3.53M 10-K · filed 2018-03-08 |
| 2015-12-31 | -$5.65M 10-K · filed 2017-03-29 |
| 2014-12-31 | -$5.46M 10-K · filed 2016-03-09 |
| 2013-12-31 | -$3.69M 10-K · filed 2015-03-26 |
| 2012-12-31 | -$2.23M 10-K · filed 2014-03-27 |
| 2011-12-31 | -$2.03M 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |